These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25743538)

  • 1. [Clostridium difficile, are all our patients diagnosed?].
    Alonso-Fernández P; Wu Lai TI; García-Salmones M; Saavedra-Cervera B; García-Salguero C; Merino P
    Rev Calid Asist; 2015; 30(2):79-85. PubMed ID: 25743538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a rapid membrane enzyme immunoassay for the simultaneous detection of glutamate dehydrogenase and toxin for the diagnosis of Clostridium difficile infection.
    Kim H; Kim WH; Kim M; Jeong SH; Lee K
    Ann Lab Med; 2014 May; 34(3):235-9. PubMed ID: 24790912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of glutamate dehydrogenase (GDH) and toxin A/B rapid tests for Clostridioides (prev. Clostridium) difficile diagnosis in a university hospital in Minas Gerais, Brazil.
    Ramos CP; Lopes EO; Diniz AN; Lobato FCF; Vilela EG; Silva ROS
    Braz J Microbiol; 2020 Sep; 51(3):1139-1143. PubMed ID: 32367261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
    Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
    J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.
    Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M
    Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
    Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
    Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens.
    Liu C; Tang C; Han Y; Xu Y; Ni F; Jin K; Liu G
    Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):345-351. PubMed ID: 32944896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Detection of
    Yoo IY; Song DJ; Huh HJ; Lee NY
    Ann Lab Med; 2019 Mar; 39(2):214-217. PubMed ID: 30430786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.
    Barkin JA; Nandi N; Miller N; Grace A; Barkin JS; Sussman DA
    Dig Dis Sci; 2012 Oct; 57(10):2592-9. PubMed ID: 22576711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First clinical and microbiological characterization of Clostridium difficile infection in a Croatian University Hospital.
    Novak A; Spigaglia P; Barbanti F; Goic-Barisic I; Tonkic M
    Anaerobe; 2014 Dec; 30():18-23. PubMed ID: 25079669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cases of Clostridium difficile infection (CDI) presenting at an emergency room: molecular and clinical features differentiate community-onset hospital-associated and community-associated CDI in a tertiary care hospital.
    Shin BM; Moon SJ; Kim YS; Shin WC; Yoo HM
    J Clin Microbiol; 2011 Jun; 49(6):2161-5. PubMed ID: 21471341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Michigan Clostridium difficile hospital discharges: frequency, mortality, and charges, 2002-2008.
    VerLee KE; Finks JL; Wilkins MJ; Wells EV
    Public Health Rep; 2012; 127(1):62-71. PubMed ID: 22298923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
    Kim J; Pai H; Seo MR; Kang JO
    J Korean Med Sci; 2011 Oct; 26(10):1258-64. PubMed ID: 22022175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care.
    Khanafer N; Touré A; Chambrier C; Cour M; Reverdy ME; Argaud L; Vanhems P
    World J Gastroenterol; 2013 Nov; 19(44):8034-41. PubMed ID: 24307797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.
    Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH
    JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece.
    Viazis N; Pontas C; Karmiris K; Dimas I; Fragaki M; Paspatis G; Drygiannakis I; Koutroubakis IE; Moschovis D; Tzouvala M; Theocharis G; Tsolias C; Thomopoulos K; Zampeli E; Axiaris G; Michopoulos S; Belesiotou E; Banasa M; Maraki S; Kouskoumpekou F; Apostolopoulos G; Stamouli V; Prifti H; Mantzaris GJ
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):773-776. PubMed ID: 30973416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.